Diabetic Macular Edema in the Western Part of Romania: Screening to Improve Patient Outcomes
Open Access
- 9 March 2025
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 15 (3) , 106
Abstract
Background: Diabetes mellitus (DM) is a global healthcare concern with a rising prevalence. Patients with DM have a severely diminished quality of life due to the extensive range of connected complications. One of the most impactful diabetes-associated pathologies is diabetic macular edema (DME), as it is a major cause of blindness globally. Patients with DME present many concomitant diseases that influence their prognosis. The present research seeks to describe the most frequent DME-related comorbidities. Method: This study enrolled 105 participants previously diagnosed with type 1 DM (T1DM) or type 2 DM (T2DM) (77 presenting with DME), who were evaluated regarding other associated comorbidities. Results: Patients in the DME group presented a median age of 65, with a mean disease duration of 15 years and inadequate glycemic control, reflected by a mean HbA1c of 7.5%. All patients presented at least one comorbidity, with hypertension (100%) and dyslipidemia (62.3%) being the most prevalent. Spearman analysis revealed a statistically significant correlation between DME and diabetes duration (p = 0.01), proliferative diabetic retinopathy (p = 0.004), and chronic kidney disease (p = 0.034). Conclusions: Patients with DME often present multiple comorbidities that must be screened for and addressed through a multidisciplinary approach.Keywords
Funding Information
- “Victor Babes” University of Medicine and Pharmacy Timisoara
This publication has 43 references indexed in Scilit:
- Risk of diabetic retinopathy and diabetic macular oedema with sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated databaseDiabetologia, 2024
- Associations between blood pressure levels and diabetic retinopathy in patients with diabetes mellitus: A population-based studyHeliyon, 2023
- Characterization of Poor Visual Outcomes of Diabetic Macular Edema: The Fight Retinal Blindness! ProjectOphthalmology Retina, 2022
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045Diabetes Research and Clinical Practice, 2022
- Characterizing Multimorbidity from Type 2 DiabetesEndocrinology and Metabolism Clinics of North America, 2021
- The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: a meta-analysisEndocrine, 2018
- Serum Lipids and Proliferative Diabetic Retinopathy and Macular Edema in Persons With Long-term Type 1 Diabetes MellitusJAMA Ophthalmology, 2015
- The Effects of Medical Management on the Progression of Diabetic Retinopathy in Persons with Type 2 DiabetesOphthalmology, 2014
- The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIIOphthalmology, 2008
- Risks of Progression of Retinopathy and Vision Loss Related to TightBlood Pressure Control in Type 2 Diabetes MellitusArchives of Ophthalmology (1950), 2004